Researchers from the Wellcome Sanger Institute and their collaborators used whole genome sequencing to study when BCR::ABL1—an abnormal fusion of the different genes called BCR and ABL1 ...

Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine ...